Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts

Byonanebye, Dathan M; Polizzotto, Mark N; Maltez, Fernando; Rauch, Andri; Grabmeier-Pfistershammer, Katharina; Wit, Ferdinand; De Wit, Stephane; Castagna, Antonella; d'Arminio Monforte, Antonella; Mussini, Cristina; Wasmuth, Jan-Christian; Fontas, Eric; Abela, Irene; Sarcletti, Mario; Bansi-Matharu, Loveleen; Jaschinski, Nadine; Peters, Lars; Hosein, Sean R; Vannappagari, Vani; Cohen, Cal; Bissio, Emiliano; Mocroft, Amanda; Law, Matthew; Ryom, Lene; Petoumenos, Kathy (2024). Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts. The Lancet : HIV, 11(5):e321-e332.